↓ Skip to main content

Treatment of thromboangiitis obliterans (Buerger's disease) with bosentan

Overview of attention for article published in BMC Cardiovascular Disorders, February 2012
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
2 tweeters

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment of thromboangiitis obliterans (Buerger's disease) with bosentan
Published in
BMC Cardiovascular Disorders, February 2012
DOI 10.1186/1471-2261-12-5
Pubmed ID
Authors

Joaquin De Haro, Francisco Acin, Silvia Bleda, Cesar Varela, Leticia Esparza

Abstract

This study assessed the effectiveness and safety of bosentan when administered to thromboangiitis obliterans (Buerger's disease) patients.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Spain 1 3%
Unknown 29 94%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 5 16%
Researcher 5 16%
Student > Master 4 13%
Student > Bachelor 4 13%
Student > Doctoral Student 3 10%
Other 6 19%
Unknown 4 13%
Readers by discipline Count As %
Medicine and Dentistry 19 61%
Nursing and Health Professions 2 6%
Sports and Recreations 2 6%
Psychology 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 0 0%
Unknown 6 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2016.
All research outputs
#6,888,731
of 12,410,115 outputs
Outputs from BMC Cardiovascular Disorders
#279
of 779 outputs
Outputs of similar age
#115,132
of 259,446 outputs
Outputs of similar age from BMC Cardiovascular Disorders
#14
of 67 outputs
Altmetric has tracked 12,410,115 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 779 research outputs from this source. They receive a mean Attention Score of 3.6. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 259,446 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.